We discovered a new class of specialized RNAs interacting with the mammalian DNMT1 – DNMT1-interacting RNAs (DiRs). DiRs prevent DNA methylation and gene silencing in a locus-specific manner, by binding and inhibiting DNMT1 are able to reactivate suppressed genes
Company Details
- Employees
- 4
- Address
- Dna Hypermethylation
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://aptadir.com/
Aptadir Therapeutics Questions
Aptadir Therapeutics's website is https://aptadir.com/
Aptadir Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aptadir_therapeutics
Aptadir Therapeutics has
4 employees.
View email and phone details for 4
employees at Aptadir Therapeutics.
Aptadir Therapeutics's industry is
Biotechnology Research
Aptadir Therapeutics's top competitors are
Wave Life Sciences,
Constructive Bio,
Camp4 Therapeutics,
Polku Therapeutics,
Genespire,
Lucid Genomics,
Lift Biosciences,
Extend | The National Technology Transfer Biotech Hub,
Angelini Ventures,
Novystem.
Aptadir Therapeutics's categories are Biotechnology Research
